|
Product and Company
|
Development Status
|
|
Diphtheria and tetanus toxoids and pertussis vaccine, Haemophilus influenzae type b, hepatitis B vaccine
|
Phase I (by summer of 1993)
|
|
Merck & Co., Inc./Connaught Laboratories, Inc.
|
|
|
Diphtheria and tetanus toxoids and pertussis vaccine, Haemophilus influenzae type b, hepatitis B vaccine and inactivated polio vaccine
|
Phase I (by summer of 1993)
|
|
Merck & Co., Inc./Connaught Laboratories, Inc.
|
|
|
Diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B and Haemophilus influenzae type b conjugate vaccine
|
Pre-clinical studies completed; preparing IND submissions
|
|
Michigan Department of Public Health/ SmithKline Beecham
|
|
|
Diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine and Haemophilus influenzae type b conjugate vaccine
|
Pre-clinical studies completed; preparing IND submissions
|
|
Michigan Department of Public Health/ SmithKline Beecham
|
|
|
Diptheria and tetanus toxoids and pertussis vaccine, adsorbed, and poliovirus vaccine, inactivated
|
PLA submitted
|
|
Connaught Laboratory, Inc./Pasteur Mérieux Sérums et Vaccins
|
|
|
Act HIBTM Haemophilus influenzae type b conjugate vaccine (tetanus protein conjugate)
|
PLA submitted
|
|
Connaught Laboratories, Inc./Pasteur Mérieus Sérums et Vaccins
|
|
|
Haemophilus influenzae type b conjugate vaccine
|
Phase III
|
|
Massachusetts Department of Public Health
|
|
|
Haemophilus influenzae type b conjugate vaccine, hepatitis B vaccine
|
Phase Ill
|
|
Merck & Co., Inc.
|
|
|
VAQTATM hepatitis A vaccine
|
Phase III
|
|
Merck & Co., Inc.
|
|
|
Hepatitis B vaccine
|
Phase II
|
|
Connaught Laboratories. Inc.
|
|
|
Hepatitis B vaccine
|
Phase III
|
|
Amgen/Johnson & Johnson
|
|
|
Herpes vaccine
|
Phase I (adults)
|
|
Lederle-Praxis Biologicals
|
|
|
PrymeTM lyme disease vaccine (recombinant OspA lipoprotein for Lyme borreliosis)
|
Phase I
|
|
Connaught Laboratories, Inc.
|
